About Zinc finger and BTB domain-containing protein 9
Zinc finger and BTB domain-containing protein 9 (ZBTB9) is a protein
from Homo sapiens identified by UniProt accession
Q96C00, 473 residues long.
MolForge cross-references it against 0 known binders and
44 disease associations.
Target properties
| Protein name | Zinc finger and BTB domain-containing protein 9 |
| UniProt accession | Q96C00 |
| Gene | ZBTB9 |
| Organism | Homo sapiens |
| Length | 473 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (44)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.39
- multiple sclerosis · score 0.35
- Parkinson disease · score 0.32
- Alzheimer disease · score 0.32
- lysosomal storage disease · score 0.32
- type 1 diabetes mellitus · score 0.24
- systolic blood pressure · score 0.14
- celiac disease · score 0.12
- diet measurement · score 0.10
- leukocyte count · score 0.10
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96C00-F1 | alphafold | PREDICTED | 59.43 | — |
Amino-acid sequence (473 residues)
METPTPLPPV PASPTCNPAP RTIQIEFPQH SSSLLESLNR HRLEGKFCDV SLLVQGRELR AHKAVLAAAS PYFHDKLLLG DAPRLTLPSV IEADAFEGLL QLIYSGRLRL PLDALPAHLL VASGLQMWQV VDQCSEILRE LETSGGGISA RGGNSYHALL STTSSTGGWC IRSSPFQTPV QSSASTESPA STESPVGGEG SELGEVLQIQ VEEEEEEEED DDDEDQGSAT LSQTPQPQRV SGVFPRPHGP HPLPMTATPR KLPEGESAPL ELPAPPALPP KIFYIKQEPF EPKEEISGSG TQPGGAKEET KVFSGGDTEG NGELGFLLPS GPGPTSGGGG PSWKPVDLHG NEILSGGGGP GGAGQAVHGP VKLGGTPPAD GKRFGCLCGK RFAVKPKRDR HIMLTFSLRP FGCGICNKRF KLKHHLTEHM KTHAGALHAC PHCGRRFRVH ACFLRHRDLC KGQGWATAHW TYK
Explore Zinc finger and BTB domain-containing protein 9 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets